TRV · sample dossier
The Travelers Companies, Inc.
71/100
OutdatedGenerated Oct 10, 2026 · 10:00 AM UTC · 3 hours ago
This copy is frozen (Oct 10). Sign in to run the same work — filings, valuation, bull and bear, sources — on any US stock or ETF, in about 90 seconds.
Run a fresh dossierTRV
EquityThe Travelers Companies, Inc.XNYS
Decision context
HOLD
84% convictionThe latest quarter is more than 100 days old, so this stays a Hold.
A mixed picture — no strong reason to buy or sell right now.
The stock trades 13.9% below our estimate.
Current price
$368.75
Estimated value range
$268.87 – $490.11
Gap vs AlphaDog estimate
+13.9%
Narrow evidence — range rests on a single usable method.
The stock trades at a discount, but execution uncertainties suggest waiting for a clearer catalyst.
Market context
Price
Price when available
Pick how far back the chart looks
1 month
+0.3%
3 months
+8.0%
6 months
+24.0%
1 year
+30.4%
Financial trajectory
Executive summary & thesis
The Travelers Companies, Inc. is a property and casualty insurer with a market capitalization of $76.91B, trading at a P/E of 9.94 and generating $51.62 in free cash flow per share.
- TRV trades at a 9.94 P/E and 7.05 EV/EBITDA, below peer CB at 12.1 P/E and WRB at 14.8 P/E.
- EPS grew 57.1% YoY for the quarter ended June 30, 2026, supporting $51.62 in TTM free cash flow per share.
- Balance sheet safety is supported by a 0.27 Debt/Equity ratio and a 17.0% net margin.
- Revenue growth slowed to 0.3% YoY for the quarter ended June 30, 2026, indicating stalled premium volume.
- The stock trades below its 50-day moving average as of October 10, 2026, despite a 30.4% 1-year return.
- EVP & Chief Risk Officer Maria Olivo sold 6,000 shares worth $2.22M on 2026-08-28.
Things to keep in mind
- 1P/E 9.9xView source
- 2Revenue growth slowed to 0.3% YoY for the quarter ended June 30, 2026, indicating stalled premium volume.View source
- 3The stock trades below its 50-day moving average as of October 10, 2026, despite a 30.4% 1-year return.View source
What to watch next
Factor profile
Value-sensitive setup
| Factor | Score |
|---|---|
| Quality | 62 out of 100 (Neutral). Business health — profits, returns, and consistency. Higher means a more durable company. |
| Growth | 60 out of 100 (Neutral). How fast sales and earnings are rising. Higher means the business is expanding faster. |
| Value | 92 out of 100 (Elite). How cheap the stock looks for what you get. Higher means a more attractive price. |
| Safety | 75 out of 100 (Strong). Balance-sheet cushion and fewer red flags. Higher means less risk of a nasty surprise. |
| Momentum | 66 out of 100 (Neutral). Recent share-price trend. Higher means buyers have been in control lately. |
Another way to look at it
A calmer look at both sides of the TRV story
The prevailing consensus rates Travelers as a high-conviction buy anchored on an optically cheap 9.9 P/E, yet it ignores a severe disconnect between top-line stagnation and unsustainable earnings leverage.
While revenue contracted sequentially from $12.47B in Q3 2025 to $12.15B in Q2 2026 with YoY growth stalling at 0.3%, reported EPS surged 57.1% YoY, indicating that margin expansion is driven by transient factors rather than structural pricing power. The market is pricing TRV at a premium P/B of 2.32 despite an asset productivity ROA of only 4.8%, creating vulnerability if loss ratios mean-revert. Furthermore, the consensus celebrates insider alignment while overlooking net insider dispositions of $7.43M over the trailing three months, led by a $2.22M divestment by the Chief Risk Officer. With the stock already slipping below its 50-day moving average after a 30.4% 1-year run, trading multiples of 7.0 EV/EBITDA reflect late-cycle peak underwriting margins rather than enduring value.
Consensus overlooks the divergence between 0.3% YoY revenue growth and 57.1% YoY EPS growth for Q2 2026, which points to temporary reserve releases or low catastrophe seasonality rather than durable franchise expansion.
The 4.8% ROA reveals weak total asset productivity that fails to support a 2.32 P/B multiple if net margins contract from the current 17.0% level.
The adversarial debate ignored conflicting cash flow figures, citing $70.84 in free cash flow per share to justify valuation while the synthesis report records $51.62 per share.
Extrapolating a 17.0% net margin and 57.1% EPS growth as sustainable baselines in property and casualty underwriting while top-line revenue declined from $12.47B to $12.15B.
Treating the 9.9 P/E and 7.0 EV/EBITDA as a margin of safety against peers CB (12.1 P/E) and WRB (14.8 P/E) without penalizing TRV for its 0.3% top-line stagnation.
Relying on trailing 30.4% 1-year momentum while discounting technical deterioration as the stock trades below its 50-day moving average with 1-month return slowing to 0.3%.
Revenue growth YoY falls below the 0.3% rate recorded for the quarter ended June 30, 2026.
EPS growth YoY drops below the 57.1% level recorded for the quarter ended June 30, 2026.
Cash after investing
See whether TRV still makes cash after it spends to grow.
- Revenue growth YoY falls below the 0.3% rate recorded for the quarter ended June 30, 2026.
- EPS growth YoY drops below the 57.1% level recorded for the quarter ended June 30, 2026.
For learning and research only — not investment advice. AlphaDog doesn’t hold stocks and isn’t your financial advisor.
Run the next one yourself.
You just read a full TRV dossier — scored verdict, valuation, and both sides, with sources. Sign in to run that on a name you hold, on current filings. A free account includes 10 credits a week, 1 per fresh run.